Yüklüyor......

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is involved in single-strand DNA breaks, which in the presence of defective homologous recombination repair lead to double-st...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Javle, M., Curtin, N. J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210467/
https://ncbi.nlm.nih.gov/pubmed/22084640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011417039
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!